Acute pan-dysautonomia as well as central nervous system involvement and peripheral neuropathies in a patient with systemic lupus erythematosus
Tóm tắt
A 32-year-old woman was diagnosed with leucopenia in 2002, being antinuclear antibody, anti-DNA antibody, and antiphospholipid antibody positive, and she was administered low-dose aspirin. In July 2006, she was admitted to our hospital because of pyrexia and abdominal pain. Examination revealed paralytic ileus, absence of the pupillary light reflex, dyshidrosis and anuresis. In addition, with high-level interleukin-6 in cerebrospinal fluid, the sensory nerve conduction velocity was derivation impotence. She was subsequently diagnosed with systemic lupus erythematosus (SLE) with central nervous system involvement, peripheral neuropathy as well as acute pan-dysautonomia. After pulse corticosteroid therapy, paralytic ileus was improved, however, the urination disorder persisted, and syncope due to orthostatic hypotension became marked. Plasma exchange and a second course of pulse corticosteroid therapy were performed, and were ineffective, whereas intravenous cyclophosphamide was effective. This patient is a rare case of central nervous system, peripheral neuropathy as well as acute pan-dysautonomia with SLE.
Tài liệu tham khảo
Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology. 2002;58:1214–20.
Ainiala H, Hietaharju A, Loukkola J, Peltola J, Korpela M, Metsanoja R, et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum. 2001;45:419–23.
Hanly JG, Urowitz MB, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ, et al. For the systemic lupus international collaborating clinics. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum. 2007;56:265–73.
ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42:599–608.
Omdal R, Jorde R, Mellgren SI, Husby G. Autonomic function in systemic lupus erythematosus. Lupus. 1994;3:413–7.
Laganá B, Tubani L, Maffeo N, Vella C, Makk E, Baratta L, et al. Heart rate variability and cardiac autonomic function in systemic lupus erythematosus. Lupus. 1996;5:49–55.
Gamez-Nava JI, Gonzalez-Lopez L, Ramos-Remus C, Fonseca-Gomez MM, Cardona-Muñoz EG, Suarez-Almazor ME. Autonomic dysfunction in patients with systemic lupus erythematosus. J Rheumatol. 1998;25:1092–6.
McCombe PA, McLeod JG, Pollard JD, Guo YP, Ingall TJ. Peripheral sensorimotor and autonomic neuropathy associated with systemic lupus erythematosus. Clinical, pathological and immunological features. Brain. 1987;110:533–49.
Young RR, Asbury AK, Adams RD, Corbett JL. Pure pan-dysautonomia with recovery. Trans Am Neurol Assoc. 1969;94:355–7.
Young RR, Asbury AK, Corbett JL, Adams RD. Pure pan-dysautonomia with recovery. Description and discussion of diagnostic criteria. Brain. 1975;98:613–36.
Suarez GA, Fealey RD, Camilleri M, Low PA. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology. 1994;44:1675–82.
Stoll G, Thomas C, Reiners K, Schober R, Hartung HP. Encephalo-myelo-radiculo-ganglionitis presenting as pandysautonomia. Neurology. 1991;41:723–6.
American College of Rheumatology: arthritis and rheumatism. http://www.rheumatology.org/publications/ar/1999/aprilappendix.asp (1999).
Hoyle C, Ewing DJ, Parker AC. Acute autonomic neuropathy in association with systemic lupus erythematosus. Ann Rheum Dis. 1985;44:420–4.
Arruda WO, Teive HA, Ramina R, Wunder PR, Rocha LC. Autonomic neuropathy in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry. 1989;52:539–40.
Jodo S, Sagawa A, Ogura N, Atsumi T, Amasaki Y, Nakabayashi T, et al. A case of systemic lupus erythematosus (SLE) developing pan-dysautonomia. Ryumachi. 1992;32:58–65. Japanese.
Law WG, Thong BY, Lian TY, Kong KO, Chng HH. Acute pan-dysautonomia: a rare initial presentation of lupus with Sjögren’s syndrome. Lupus. 2006;15:899–900.
Low PA, Vernino S, Suarez G. Autonomic dysfunction in peripheral nerve disease. Muscle Nerve. 2003;27:646–61.
Vernino S, Adamski J, Kryzer TJ, Fealey RD, Lennon VA. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology. 1998;50:1806–13.
Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343:847–55.
Kusunoki S. Antiglycolipid antibodies in Guillain–Barré syndrome and autoimmune neuropathies. Am J Med Sci. 2000;319:234–9.
Kusunoki S, Morita D, Ohminami S, Hitoshi S, Kanazawa I. Binding of immunoglobulin G antibodies in Guillain–Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications. Muscle Nerve. 2003;27:302–6.
Kaida K, Morita D, Kanzaki M, Kamakura K, Motoyoshi K, Hirakawa M, et al. Ganglioside complexes as new target antigens in Guillain–Barré syndrome. Ann Neurol. 2004;56:567–71.
DeGiorgio L, Konstantinov KN, Lee SC, et al. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 2001;7:1189–93.
Sakic B, Kirkham DL, Ballok DA, et al. Proliferating brain cells a target of neurotoxic CSF insystemic autoimmune disease. J Neuroimmunol. 2005;169:68–85.
Hanly JG, Robichaud J, Fisk JD. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J Rheumatol. 2006;33:1553–8.
Lapteva L, Nowak M, Yarboro CH, Takada K, Roebuck-Spencer T, Weickert T, et al. Anti-N-methyl-d-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum. 2006;54:2505–14.